$269 Million is the total value of Tri Locum Partners LP's 59 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 370.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Buy | LILLY ELI & COunit | $25,497,974 | +67.0% | 54,369 | +22.3% | 9.48% | +103.8% |
| JNJ | New | JOHNSON & JOHNSON | $21,080,958 | – | 127,362 | +100.0% | 7.84% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $14,377,749 | +56.2% | 200,080 | +34.1% | 5.34% | +90.7% |
| MDT | New | MEDTRONIC PLC | $14,154,146 | – | 160,660 | +100.0% | 5.26% | – |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $9,816,097 | +60.6% | 96,274 | +43.3% | 3.65% | +96.0% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $8,655,930 | – | 24,597 | +100.0% | 3.22% | – |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $8,326,448 | -7.1% | 1,105,770 | +9.2% | 3.10% | +13.4% |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $8,060,495 | – | 116,768 | +100.0% | 3.00% | – |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $7,953,889 | +135.7% | 4,099,943 | +5.7% | 2.96% | +187.5% |
| DXCM | New | DEXCOM INC | $6,656,561 | – | 51,798 | +100.0% | 2.47% | – |
| NARI | New | INARI MED INC | $6,595,460 | – | 113,441 | +100.0% | 2.45% | – |
| SILK | New | SILK RD MED INC | $6,450,305 | – | 198,532 | +100.0% | 2.40% | – |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $6,008,310 | +79.1% | 26,010 | +87.9% | 2.23% | +118.5% |
| IMGN | New | IMMUNOGEN INC | $5,619,618 | – | 297,807 | +100.0% | 2.09% | – |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $5,617,314 | +179.0% | 4,884,621 | +96.3% | 2.09% | +240.6% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,604,370 | – | 29,506 | +100.0% | 2.08% | – |
| ALPN | New | ALPINE IMMUNE SCIENCES INC | $3,412,878 | – | 331,992 | +100.0% | 1.27% | – |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $3,196,241 | +62.7% | 151,194 | +54.6% | 1.19% | +98.7% |
| ETNB | Buy | 89BIO INC | $3,143,748 | +31.3% | 165,897 | +5.5% | 1.17% | +60.2% |
| EDIT | New | EDITAS MEDICINE INC | $3,052,318 | – | 370,877 | +100.0% | 1.13% | – |
| MRUS | New | MERUS N V | $2,677,524 | – | 101,691 | +100.0% | 1.00% | – |
| NTRA | New | NATERA INC | $2,577,228 | – | 52,964 | +100.0% | 0.96% | – |
| VERA | New | VERA THERAPEUTICS INCcl a | $1,748,294 | – | 108,928 | +100.0% | 0.65% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $1,409,130 | – | 428,307 | +100.0% | 0.52% | – |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $1,312,673 | – | 41,292 | +100.0% | 0.49% | – |
| PMVP | New | PMV PHARMACEUTICALS INC | $991,665 | – | 158,413 | +100.0% | 0.37% | – |
| IMTX | New | IMMATICS N.V | $946,880 | – | 82,052 | +100.0% | 0.35% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $874,382 | – | 24,201 | +100.0% | 0.32% | – |
| SDGR | New | SCHRODINGER INC | $821,783 | – | 16,462 | +100.0% | 0.30% | – |
| COGT | New | COGENT BIOSCIENCES INC | $791,918 | – | 66,885 | +100.0% | 0.29% | – |
| CBAY | New | CYMABAY THERAPEUTICS INC | $772,939 | – | 70,588 | +100.0% | 0.29% | – |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $613,032 | – | 73,067 | +100.0% | 0.23% | – |
| INBX | New | INHIBRX INC | $396,357 | – | 15,268 | +100.0% | 0.15% | – |
| FGEN | New | FIBROGEN INCput | $330,750 | – | 122,500 | +100.0% | 0.12% | – |
| DOV | New | DOVER CORP | $223,247 | – | 1,512 | +100.0% | 0.08% | – |
| APH | New | AMPHENOL CORP NEWcl a | $223,334 | – | 2,629 | +100.0% | 0.08% | – |
| HIG | New | HARTFORD FINL SVCS GROUP INC | $218,509 | – | 3,034 | +100.0% | 0.08% | – |
| PRU | New | PRUDENTIAL FINL INC | $217,286 | – | 2,463 | +100.0% | 0.08% | – |
| CL | New | COLGATE PALMOLIVE CO | $208,085 | – | 2,701 | +100.0% | 0.08% | – |
| CTAS | New | CINTAS CORP | $205,791 | – | 414 | +100.0% | 0.08% | – |
| BRKB | New | BERKSHIRE HATHAWAY INC DELcl b new | $200,508 | – | 588 | +100.0% | 0.08% | – |
| KMI | New | KINDER MORGAN INC DEL | $177,779 | – | 10,324 | +100.0% | 0.07% | – |
| AM | Buy | ANTERO MIDSTREAM CORP | $135,430 | +16.2% | 11,675 | +5.0% | 0.05% | +38.9% |
| NRZ | New | RITHM CAPITAL CORP | $126,515 | – | 13,531 | +100.0% | 0.05% | – |
| JBLU | New | JETBLUE AWYS CORP | $123,074 | – | 13,891 | +100.0% | 0.05% | – |
| VTRS | New | VIATRIS INC | $103,582 | – | 10,379 | +100.0% | 0.04% | – |
| UA | New | UNDER ARMOUR INCcl c | $77,856 | – | 11,603 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.